# Generation Bio Co.

Generation Bio Co. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** Generation Bio Co.
- **Former names in filing history:** Generation Bio Co. (2018-03-05 to 2026-05-14)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001733294

## About

Generation Bio Co. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001733294, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-13, it reported annual revenue of USD 19,892,000; net income of USD -131,668,000; total assets of USD 231,197,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $19.9M (USD 19,892,000)
- **Net income:** -$131.7M (USD -131,668,000)
- **Total assets:** $231.2M (USD 231,197,000)
- **Cash and equivalents:** $76.3M (USD 76,301,000)
- **Operating cash flow:** -$88.6M (USD -88,563,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $5.9M (USD 5,904,000)
- **Net income:** -$126.6M (USD -126,612,000)
- **Total assets:** $374.8M (USD 374,758,000)
- **Cash and equivalents:** $66.4M (USD 66,446,000)
- **Operating cash flow:** -$52.7M (USD -52,745,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$136.6M (USD -136,639,000)
- **Total assets:** $376.3M (USD 376,264,000)
- **Cash and equivalents:** $93.2M (USD 93,171,000)
- **Operating cash flow:** -$102.4M (USD -102,448,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$119.2M (USD -119,151,000)
- **Total assets:** $476.8M (USD 476,771,000)
- **Cash and equivalents:** $375.1M (USD 375,145,000)
- **Operating cash flow:** -$91.8M (USD -91,821,000)

## Recent SEC filings

- Form 8-K — filed 2026-02-09 — period 2026-02-06 — 8-K
- Form 8-K — filed 2025-12-15 — period 2025-12-15 — 8-K
- Form 10-Q — filed 2025-11-05 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-05 — period 2025-11-05 — 8-K
- Form 8-K — filed 2025-10-22 — period 2025-10-21 — 8-K
- Form 10-Q — filed 2025-08-12 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-12 — period 2025-08-12 — 8-K
- Form 8-K — filed 2025-07-18 — period 2025-07-18 — 8-K
- Form 8-K — filed 2025-06-05 — period 2025-06-04 — 8-K
- Form 10-Q — filed 2025-05-07 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-07 — period 2025-05-07 — 8-K
- Form DEF 14A — filed 2025-04-23 — period 2025-06-04 — DEF 14A

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/generation-bio-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology